Financial Enhancement Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,818
Closed -$1.06M 138
2024
Q3
$1.06M Buy
+41,818
New +$1.06M 0.21% 76
2023
Q2
Sell
-41,818
Closed -$1.06M 125
2023
Q1
$1.06M Buy
+41,818
New +$1.06M 0.21% 76